GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: TBI-223 is an oxazolidinone class antibacterial with potent antimycobacterial activity. It is being clinically evaluated as a treatment for tuberculosis (TB).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| methyl N-[[(5S)-3-[3-fluoro-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]carbamate |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
TBI-223 |
| Other databases | |
| CAS Registry No. | 2071265-08-0 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL5201490 |
| GtoPdb PubChem SID | 485206150 |
| PubChem CID | 126494519 |
| Search Google for chemical match using the InChIKey | ZNBRXLSWXJKKLJ-LBPRGKRZSA-N |
| Search Google for chemicals with the same backbone | ZNBRXLSWXJKKLJ |
| UniChem Compound Search for chemical match using the InChIKey | ZNBRXLSWXJKKLJ-LBPRGKRZSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZNBRXLSWXJKKLJ-LBPRGKRZSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
TBI-223 (links to external site)
Cat. No. HY-139398 |